TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Entity Common Stock, Shares Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Teva Pharmaceutical Industries Ltd quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Teva Pharmaceutical Industries Ltd Entity Common Stock, Shares Outstanding for the quarter ending June 30, 2024 was 1.13B shares, a 1.09% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.13B +12.3M +1.09% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 1.13B +12.2M +1.09% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.12B +10.2M +0.92% Dec 31, 2023 10-K 2024-02-12
Q3 2023 1.12B +10.3M +0.93% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.12B +10.1M +0.91% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 1.12B +10.1M +0.91% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.11B +7.57M +0.69% Dec 31, 2022 10-K 2023-02-10
Q3 2022 1.11B +7.64M +0.69% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 1.11B +7.68M +0.7% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 1.11B +8M +0.73% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 1.1B +6.82M +0.62% Dec 31, 2021 10-K 2022-02-09
Q3 2021 1.1B +7.04M +0.64% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 1.1B +7.11M +0.65% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 1.1B +6.82M +0.62% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 1.1B +4.32M +0.4% Dec 31, 2020 10-K 2021-02-10
Q3 2020 1.1B +3.88M +0.36% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 1.1B +3.87M +0.35% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 1.1B +3.93M +0.36% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 1.09B +2.8M +0.26% Dec 31, 2019 10-K 2020-02-21
Q3 2019 1.09B +73.4M +7.2% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 1.09B +73.6M +7.23% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 1.09B +73.4M +7.21% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 1.09B Dec 31, 2018 10-K 2019-02-19
Q3 2018 1.02B -105M -9.32% Oct 30, 2018 10-Q 2018-11-01
Q2 2018 1.02B -105M -9.36% Jul 30, 2018 10-Q 2018-08-02
Q1 2018 1.02B -105M -9.36% Apr 30, 2018 10-Q 2018-05-03
Q3 2017 1.12B +850K +0.08% Sep 30, 2017 6-K 2017-11-02
Q2 2017 1.12B +101M +9.89% Jun 30, 2017 6-K 2017-08-03
Q1 2017 1.12B +101M +9.9% Mar 31, 2017 6-K 2017-05-11
Q4 2016 1.12B +107M +10.6% Dec 31, 2016 10-K 2018-02-12
Q3 2016 1.12B +161M +16.8% Sep 30, 2016 6-K 2016-11-15
Q2 2016 1.02B +62.6M +6.52% Jun 30, 2016 6-K 2016-08-04
Q1 2016 1.02B +63M +6.56% Mar 31, 2016 6-K 2016-05-09
Q4 2015 1.02B +59.5M +6.22% Dec 31, 2015 20-F 2016-02-11
Q3 2015 961M +9.02M +0.95% Sep 30, 2015 6-K 2015-10-29
Q2 2015 960M +9.15M +0.96% Jun 30, 2015 6-K 2015-07-30
Q1 2015 959M +10.3M +1.08% Mar 31, 2015 6-K 2015-04-30
Q4 2014 957M +9.68M +1.02% Dec 31, 2014 20-F 2015-02-09
Q3 2014 952M +7.7M +0.82% Sep 30, 2014 6-K 2014-10-30
Q2 2014 951M +6.52M +0.69% Jun 30, 2014 6-K 2014-07-31
Q1 2014 949M +5.26M +0.56% Mar 31, 2014 6-K 2014-05-02
Q4 2013 947M +3.25M +0.34% Dec 31, 2013 20-F 2014-02-10
Q3 2013 944M +1.3M +0.14% Sep 30, 2013 6-K 2013-10-31
Q2 2013 944M +1.21M +0.13% Jun 30, 2013 6-K 2013-08-01
Q1 2013 944M +1.39M +0.15% Mar 31, 2013 6-K 2013-05-02
Q4 2012 944M +1.63M +0.17% Dec 31, 2012 20-F 2013-02-12
Q3 2012 943M +2.49M +0.27% Sep 30, 2012 6-K 2012-11-01
Q2 2012 943M +2.73M +0.29% Jun 30, 2012 6-K 2012-08-02
Q1 2012 942M +2.71M +0.29% Mar 31, 2012 6-K 2012-05-09
Q4 2011 942M +4.49M +0.48% Dec 31, 2011 20-F 2012-02-17
Q3 2011 941M Sep 30, 2011 6-K 2011-11-02
Q2 2011 940M Jun 30, 2011 6-K 2011-07-28
Q1 2011 940M Mar 31, 2011 6-K 2011-05-11
Q4 2010 937M Dec 31, 2010 20-F 2011-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.